J&J Close to Settling Off-Label Probes

By

Jonathan D. Rockoff and

Joann S. Lublin

Updated June 20, 2012 6:31 p.m. ET

Johnson & Johnson and the Justice Department are close to settling a protracted investigation into the company's promotion of the antipsychotic Risperdal, for what would be one of the highest sums to date in a drug-marketing case, according to people familiar with the matter.

The sides are trying to wrap together a number of lawsuits, state investigations and other probes of alleged illegal marketing, and are discussing a payment...